Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

17%

1 trials in Phase 3/4

Results Transparency

0 of 4 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A

2(66.7%)

Phase 3

1(33.3%)

3Total

N/A(2)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials

NCT06476392Phase 3Completed

Melatonin fOr CHronic bAck Pain (The MOCHA Trial)

Role: collaborator

NCT06361914Not ApplicableActive Not Recruiting

Digital CBT-I for Patients With Chronic Pain and Insomnia

Role: collaborator

NCT04436341Completed

Epileptic Activity in Patients With Alzheimer's Disease and Lewy Body Dementia

Role: collaborator

NCT06368531Completed

Long-term Monitoring of Sleep with Ear-EEG in Patients with Chronic Pain

Role: collaborator

NCT06711159Recruiting

SLEEPINESS - a Search for a Biomarker of Excessive Daytime Sleepiness in Severe Obstructive Sleep Apnoea - An Explorative Study

Role: collaborator

NCT03022058Not ApplicableCompleted

Evaluation of the EarEEG System for Detection of Hypoglycaemia-induced Changes in the EEG in Subjects With Type 1 Diabetes

Role: collaborator

All 6 trials loaded